• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home Posts by “Healthday News”
View Post

Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus

In HealthDay News
by Healthday
March 16, 2022

For percentage of patients achieving specified reduction in disease activity, iberdomide superior to placebo only at highest dose tested

View Post

Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease

In HealthDay News
by Healthday
March 11, 2022

No improvement seen in prediction of CV events using expanded model with cardiac biomarkers and Framingham Risk Score

View Post

YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites

In HealthDay News
by Healthday
March 11, 2022

Physician, nonphysician health professionals, and other videos were all of higher quality than patient videos

View Post

Debt Valuation of Private Equity-Backed Dermatology Groups Down

In HealthDay News
by Healthday
March 9, 2022

Valuation of debt instruments significantly decreased from May to August 2019, followed by further decrease during COVID-19

View Post

Lymph Node Dissection Declining in SLN-Positive Melanoma

In HealthDay News
by Healthday
March 9, 2022

From 2017 to 2019, increase seen in use of adjuvant systemic therapy, with variation in use among treating centers

View Post

American Academy of Allergy, Asthma & Immunology, Feb. 25 to 28

In HealthDay News
by Healthday
March 7, 2022

The 2022 Annual Meeting of the American College of Allergy, Asthma & Immunology

View Post

Patients With Inflammatory Skin Diseases Have High Stress Scores

In HealthDay News
by Healthday
March 2, 2022

For those with adult acne, atopic dermatitis, psoriasis, the more severe the condition, the higher the perceived stress scores

View Post

Overall Risk for Acne Comparable for Adults With Dermatitis, Controls

In HealthDay News
by Healthday
March 2, 2022

Risk for severe acne lower for atopic dermatitis patients than controls, with the reduced risk driven by adolescents, young adults

View Post

Spironolactone Use Not Linked to Increased Risk for Cancer

In HealthDay News, OBGYN & Women's Health
by Healthday
February 23, 2022

No significant associations seen for spironolactone with risk for breast, ovarian, bladder, kidney, gastric, esophageal cancers

View Post

Model May Predict PsA Risk in Patients With Plaque Psoriasis

In HealthDay News
by Healthday
February 17, 2022

Variables in the model include age at onset, duration, nail involvement, erythematous lunula, onychorrhexis, oil drop, subungual hyperkeratosis

  • Page 1 of 151
  • 1
  • 2
  • 3
  • ...
  • 151
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Mar    

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer